Other captive investment companies
LYNGEN BIOMED AS
Revenue 2025
NOK 0
Operating profit
NOK −18,000
Equity
NOK −280,000
Incorporated
2012
Share capital
NOK 30,000
Key figures · 2025
Current ratio
0.64
Equity ratio
-55.6%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -3.5% | |
| Likviditet | ||
| Current ratio | 0.64 | |
| Working capital | −280k | |
| Soliditet | ||
| Equity ratio (%%) | -55.6% | |
| Debt-to-equity ratio | -2.80 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.